Trial Profile
Reversibility of rocuronium-induced profound neuromuscular blockade with sugammadex in pediatric patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Feb 2020
Price :
$35
*
At a glance
- Drugs Sugammadex (Primary)
- Indications Neuromuscular blockade
- Focus Therapeutic Use
- 14 Mar 2014 New trial record